DSM-5 framework
Supports clinical alignment around Major and Mild Neurocognitive Disorders, including stage-aware care planning.
Patient workspace
Clinical evidence
Evidence & presentation plan
MEDICHARM connects evidence-based non-pharmacological interventions with an infrastructure designed for the North Eastern Region’s languages, distances, and connectivity realities.
Supports clinical alignment around Major and Mild Neurocognitive Disorders, including stage-aware care planning.
Informs prevention, intervention, and whole-family care considerations across the dementia journey.
Anchors the product direction in Indian community-level dementia care practices and caregiver realities.
Guides the inclusive language strategy under India’s Unified Language Interface ecosystem.
SIH 2026 framing
The value proposition is clear: bring culturally familiar, clinically informed dementia support closer to every family — including when a reliable network is not nearby.
Problem statement
SIH26003 · AI-Based Cognitive Gaming and Memory Assistance Platform for Elderly Dementia Patients in NER
Team JOLLY ROGERS
Suggested presentation flow
The NER dementia-care gap: language, distance, and caregiver load.
Who MEDICHARM serves: MCI (MMSE 21–26) and moderate dementia (MMSE 10–20).
The care experience: reminiscence therapy, cognitive stimulation, and sundowning support.
The technical edge: Bhashini-aligned language design, local AI, and an edge–cloud split.
Safety and trust: caregiver support, location check-ins, pill adherence, and privacy-by-design.
Proof and next steps: clinical references, pilot outcomes, and partnership readiness.
Important clinical boundary
MMSE ranges and behavioral-support recommendations should be reviewed by qualified clinicians. Care plans, consent, contact escalation, and any medical advice must be individualized by the patient’s healthcare team.
Privacy, informed consent, and caregiver dignity are first-class product requirements.